Guillaume Cazoulat

Dr. Guillaume Cazoulat


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2020 in Medical Physics
Verified
Journal Article
Closed access
PDF file
GCGuillaume Cazoulat
Guillaume Cazoulat
JBJames M. Balter
James M. Balter
MMMartha M. Matuszak
Martha M. Matuszak
SJShruti Jolly
Shruti Jolly
DODawn Owen
Dawn Owen
KBKristy K. Brock
Kristy K. Brock

1 March 2020 in Advances in Radiation Oncology
Verified
Journal Article
Open access
GCGuillaume Cazoulat
Guillaume Cazoulat
DEDalia Elganainy
Dalia Elganainy
BABrian Mark Anderson
Brian Mark Anderson
MZMohamed Zaid
Mohamed Zaid
PPPeter C. Park
Peter C. Park
KBKristy K. Brock
Kristy K. Brock
Deformable image registration (DIR) of longitudinal liver cancer computed tomographic (CT) images can be challenging owing to anatomic changes caused by radiation therapy (RT) or disease progression. We propose a workflow for the DIR of longitudinal contrast-enhanced CT scans of liver cancer based on a biomechanical model of the liver driven by boundary conditions on the liver surface and centerline of an autosegmentation of the vasculature. Pre- and post-RT CT scans acquired with a median gap of 112 (32-217) days for 28 patients who underwent RT for intrahepatic cholangiocarcinoma were retrospectively analyzed. For each patient, 5 corresponding anatomic landmarks in pre- and post-RT scans were identified in the liver by a clinical expert for evaluation of the accuracy of different DIR strategies. The first strategy corresponded to the use of a biomechanical model-based DIR method with boundary conditions specified on the liver surface (BM_DIR). The second strategy corresponded to the use of an expansion of BM_DIR consisting of the auto-segmentation of the liver vasculature to determine additional boundary conditions in the biomechanical model (BM_DIR_VBC). The 2 strategies were also compared with an intensity-based DIR strategy using a Demons algorithms. The group mean target registration errors were 12.4 ± 7.5, 7.7 ± 3.7 and 4.4 ± 2.5 mm, for the Demons, BM_DIR and BM_DIR_VBC, respectively. In regard to the large and complex deformation observed in this study and the achieved accuracy of 4.4 mm, the proposed BM_DIR_VBC method might reveal itself as a valuable tool in future studies on the relationship between delivered dose and treatment outcome.

1 May 2019 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
ZYZhiyong Yang
Zhiyong Yang
YCYu Chang
Yu Chang
Kristy K BrockKristy K Brock
Kristy K Brock
GCGuillaume Cazoulat
Guillaume Cazoulat
EKEugene J. Koay
Eugene J. Koay
HLHeng Li
Heng Li

1 December 2011 in Cancer/Radiothérapie
Verified
Journal Article
Open access
GCGuillaume Cazoulat
Guillaume Cazoulat
MLM. Lesaunier
M. Lesaunier
ASA. Simon
A. Simon
PHP. Haigron
P. Haigron
OAO. Acosta
O. Acosta
RCR. de Crevoisier
R. de Crevoisier
In case of tumour displacement, image-guided radiotherapy (IGRT) based on the use of cone beam CT (tomographie conique) allows replacing the tumour under the accelerator by rigid registration. Anatomical deformations require however replanning, involving an estimation of the cumulative dose, session after session. This is the objective of this study. Two examples of arc-intensity modulated radiotherapy are presented: a case of prostate cancer (total dose=80 Gy) with tomographie conique (daily prostate registration) and one head and neck cancer (70 Gy). For the head and neck cancer, the patient had a weekly scanner allowing a dose distribution calculation. The cumulative dose was calculated per voxel on the planning CT after deformation of the dose distribution (with trilinear interpolation) following the transformation given by a non-rigid registration step (Demons registration method) from: either the tomographie conique (prostate), or the weekly CT. The cumulative dose was eventually compared with the planned dose. In cases of prostate irradiation, the "cumulative" dose corresponded to the planned dose to the prostate. At the last week of irradiation, it was above the planned dose for the rectum and bladder. The volume of rectal wall receiving more than 50 Gy (V50) was 20% at the planning and 26% at the end of treatment, increasing the risk of rectal toxicity (NTCP) of 14%. For the bladder wall, V50 were 73% and 82%, respectively. In head and neck, the "cumulative" dose to the parotid exceeded the planned dose (mean dose increasing from 46 Gy to 54 Gy) from the 5th week of irradiation on, suggesting the need for replanning within the first 5 weeks of radiotherapy. The deformable registration estimates the cumulative dose delivered in the different anatomical structures. Validation on digital and physical phantoms is however required before clinical evaluation.

12 August 2021 in Medical Physics
Verified
Journal Article
Closed access
PDF file
GCGuillaume Cazoulat
Guillaume Cazoulat
BABrian M. Anderson
Brian M. Anderson
MMMolly M. McCulloch
Molly M. McCulloch
BRBastien Rigaud
Bastien Rigaud
EKEugene J. Koay
Eugene J. Koay
KBKristy K. Brock
Kristy K. Brock

26 July 2021 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
PDF file
YHYulun He
Yulun He
GCGuillaume Cazoulat
Guillaume Cazoulat
CWCarol C. Wu
Carol C. Wu
CPChristine Peterson
Christine Peterson
MMMolly McCulloch
Molly McCulloch
Kristy K BrockKristy K Brock
Kristy K Brock
Purpose Re-planning for four-dimensional computed tomography (4DCT)-based lung adaptive radiotherapy commonly requires deformable dose mapping between the planning average-intensity image (AVG) and the newly acquired AVG. However, such AVG-AVG deformable image registration (DIR) lacks accuracy assessment. The current work quantified and compared geometric accuracies of AVG-AVG DIR and corresponding phase-phase DIRs, and subsequently investigated the clinical impact of such AVG-AVG DIR on deformable dose mapping. Methods and Materials Hybrid intensity-based AVG-AVG and phase-phase DIRs were performed between the planning and mid-treatment 4DCTs of 28 non-small cell lung cancer patients. An automated landmark identification algorithm detected vessel bifurcation pairs in both lungs. Target registration error (TRE) of these landmark pairs was calculated for both DIR types. The correlation between TRE and respiratory-induced landmark motion in the planning 4DCT was analyzed. Global and local dose metrics were used to assess the clinical implications of AVG-AVG deformable dose mapping with both DIR types. Results TRE of AVG-AVG and phase-phase DIRs averaged 3.2 ± 1.0 and 2.6 ± 0.8 mm respectively (p < 0.001). Using AVG-AVG DIR, TREs for landmarks with <10 mm motion averaged 2.9 ± 2.0 mm, compared to 3.1 ± 1.9 mm for the remaining landmarks (p < 0.01). Comparatively, no significant difference was demonstrated for phase-phase DIRs. Dosimetrically, no significant difference in global dose metrics was observed between doses mapped with AVG-AVG DIR and the phase-phase DIR, but a positive linear relationship existed (p = 0.04) between the TRE of AVG-AVG DIR and local dose difference. Conclusions When the region of interest experiences <10 mm respiratory-induced motion, AVG-AVG DIR may provide sufficient geometric accuracy; conversely, extra attention is warranted, and phase-phase DIR is recommended. Dosimetrically, the differences in geometric accuracy between AVG-AVG and phase-phase DIRs did not impact global lung-based metrics. However, as more localized dose metrics are needed for toxicity assessment, phase-phase DIR may be required as its lower mean TRE improved voxel-based dosimetry.